• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对食蟹猴进行宫内给予奎纳克林后的药代动力学研究。

Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys.

作者信息

Dubin N H, Blake D A, DiBlasi M C, Parmley T H, King T M

出版信息

Fertil Steril. 1982 Dec;38(6):735-40. doi: 10.1016/s0015-0282(16)46703-8.

DOI:10.1016/s0015-0282(16)46703-8
PMID:7141014
Abstract

Recent efforts have been made to develop a chemical oviductal occluding agent. Intrauterine quinacrine has been used in certain areas of the world with moderate success in effected tubal closure. This report presents the pharmacokinetics of a quinacrine solution (30 mg) as administered to cynomolgus monkeys via the intrauterine route, compared with intravascular injection. The data show rapid transfer of the drug from the uterine to the vascular compartment and uptake by almost all tissues examined. Although plasma concentrations disappear within 24 hours, levels can be detected in most tissues for at least 1 week following intrauterine injection. After 28 days, however, tissue levels of the drug are absent or near the limit of detection.

摘要

最近人们致力于开发一种化学输卵管闭塞剂。在世界某些地区,子宫内使用奎纳克林在实现输卵管闭合方面取得了一定成功。本报告介绍了通过子宫内途径给食蟹猴施用的奎纳克林溶液(30毫克)的药代动力学,并与血管内注射进行了比较。数据显示药物从子宫迅速转移到血管腔,并被几乎所有检测的组织摄取。虽然血浆浓度在24小时内消失,但子宫内注射后至少1周在大多数组织中都能检测到药物水平。然而,28天后,药物的组织水平不存在或接近检测限。

相似文献

1
Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys.对食蟹猴进行宫内给予奎纳克林后的药代动力学研究。
Fertil Steril. 1982 Dec;38(6):735-40. doi: 10.1016/s0015-0282(16)46703-8.
2
Effect of intrauterine administration of tetracyclines on cynomolgus monkeys.宫内给予四环素对食蟹猴的影响。
Contraception. 1984 Jun;29(6):561-71. doi: 10.1016/s0010-7824(84)80018-9.
3
Toxic effects of quinacrine hydrochloride in rhesus monkeys.
Contraception. 1981 Sep;24(3):269-74. doi: 10.1016/0010-7824(81)90039-1.
4
Effect of intrauterine and intravascular quinacrine administration on histopathology, blood chemistry, and hematology in cynomolgus monkeys.
Fertil Steril. 1982 Dec;38(6):741-7. doi: 10.1016/s0015-0282(16)46704-x.
5
Lack of tubal occlusion by intrauterine quinacrine and tetracycline in the primate.灵长类动物中宫内注射阿的平和四环素后输卵管未闭塞
Contraception. 1984 Aug;30(2):161-7. doi: 10.1016/0010-7824(84)90100-8.
6
Clinicopathologic study of fallopian tube closure after single transcervical insertion of quinacrine pellets.经宫颈单次植入阿的平栓后输卵管闭合的临床病理研究
Int J Fertil Menopausal Stud. 1995 Jan-Feb;40(1):47-54.
7
Efficacy and safety of repeated transcervical quinacrine pellet insertions for female sterilization.经宫颈重复插入喹吖因栓进行女性绝育的有效性和安全性。
Fertil Steril. 1993 Feb;59(2):301-4. doi: 10.1016/s0015-0282(16)55711-2.
8
[Non-surgical female sterilization using quinacrine: efficacy of two insertions of quinacrine pellets].[使用阿的平进行非手术女性绝育:两次植入阿的平药丸的效果]
Rev Fr Gynecol Obstet. 1993 Mar;88(3):147-50.
9
Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling.利用基于生理的药代动力学模型,从食蟹猴的药代动力学外推得出的人血浆细胞色素P450探针浓度。
Xenobiotica. 2015;45(10):881-6. doi: 10.3109/00498254.2015.1028511. Epub 2015 Jun 15.
10
A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats.喹吖因经子宫角给药雌性大鼠的终生癌症生物测定。
Regul Toxicol Pharmacol. 2010 Mar;56(2):156-65. doi: 10.1016/j.yrtph.2009.07.008. Epub 2009 Jul 23.

引用本文的文献

1
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.抗疟药物对神经炎症的影响——在治疗 COVID-19 相关神经系统并发症方面的潜在应用。
Mol Neurobiol. 2021 Jan;58(1):106-117. doi: 10.1007/s12035-020-02093-z. Epub 2020 Sep 8.
2
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial.喹吖因治疗人类朊病毒病的安全性和有效性(PRION-1研究):一项患者偏好试验。
Lancet Neurol. 2009 Apr;8(4):334-44. doi: 10.1016/S1474-4422(09)70049-3. Epub 2009 Mar 9.
3
A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie.
奎纳克林治疗朊病毒疾病失败的一种可能的药理学解释:羊瘙痒病模型中的药代动力学研究
Br J Pharmacol. 2005 Feb;144(3):386-93. doi: 10.1038/sj.bjp.0706072.